However, the dynamics and roles of CD4+ and CD8+ T cells, CD19+ B cells, and CD56+ NK cells in the patients with oral squamous cell carcinoma during treatment remain unclear. This evidence concerns the gene CD8A and oral cavity squamous cell carcinoma.